Skip to main content
Top
Published in: Annals of Hematology 1/2006

01-01-2006 | Original Article

Genomewide linkage analysis of soluble transferrin receptor plasma levels

Authors: Angel F. Remacha, Joan C. Souto, José Manuel Soria, Alfonso Buil, M. Pilar Sardà, Mark Lathrop, John Blangero, Laura Almasy, Jordi Fontcuberta

Published in: Annals of Hematology | Issue 1/2006

Login to get access

Abstract

Genetic control of soluble transferrin receptor (sTfR) levels was demonstrated using family-based studies (GAIT, Genetic Analysis of Idiopathic Thrombophilia project); moreover, a genetic relationship was observed between sTfR and the risk for thrombosis, suggesting that these phenotypes shared genetic determinants. We studied the regions that control sTfR. To assess such regions, a full genome scan was carried out using 604 highly polymorphic deoxyribonucleic acid markers (resolution 7.3 cM) in 21 extended pedigrees (358 individuals). Then, a quantitative trait linkage analysis was performed using variance components methods. The genomewide scan linkage analysis showed two regions (quantitative trait locus or QTL) with significant limit of detection (LOD) scores (2q23.14, LOD score=2.64, nominal p=0.00024; 3q21.2, LOD score=1.94, nominal p=0.0014). There were no obvious candidate genes in these regions. In conclusion, this linkage analysis suggested the existence of a QTL in 2q23.14 that probably harbored a gene (or genes) controlling sTfR levels. Moreover, a second linkage signal was observed in 3q21.2; albeit the evidence for this second locus was lower. The next step will be to identify the gene(s) and its possible involvement in thrombosis and iron homeostasis.
Literature
1.
go back to reference Blangero J, Williams JT, Almasy L (2003) Novel family-based approaches to genetic risk in thrombosis. J Thromb Haemost 1:1391–1397CrossRefPubMed Blangero J, Williams JT, Almasy L (2003) Novel family-based approaches to genetic risk in thrombosis. J Thromb Haemost 1:1391–1397CrossRefPubMed
2.
go back to reference Gambaro G, Anglani F, D’Angelo A (2000) Association studies of genetic polymorphisms and complex disease. Lancet 355:308–311CrossRefPubMed Gambaro G, Anglani F, D’Angelo A (2000) Association studies of genetic polymorphisms and complex disease. Lancet 355:308–311CrossRefPubMed
3.
go back to reference Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J (2000) Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 67:1452–1459CrossRefPubMed Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J (2000) Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 67:1452–1459CrossRefPubMed
4.
go back to reference Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, Blangero J, Fontcuberta J (2003) Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project. Thromb Haemost 89:468–474PubMed Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, Blangero J, Fontcuberta J (2003) Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project. Thromb Haemost 89:468–474PubMed
5.
go back to reference Almasy L, Soria JM, Souto JC, Coll I, Bacq D, Faure A, Mateo J, Borrell M, Muñoz X, Sala N, Stone WH, Lathrop M, Fontcuberta J, Blangero J (2003) A quantitative trait locus influencing free plasma protein S levels on human chromosome 1q. Results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. Arterioscler Thromb Vasc Biol 23:508–511CrossRefPubMed Almasy L, Soria JM, Souto JC, Coll I, Bacq D, Faure A, Mateo J, Borrell M, Muñoz X, Sala N, Stone WH, Lathrop M, Fontcuberta J, Blangero J (2003) A quantitative trait locus influencing free plasma protein S levels on human chromosome 1q. Results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. Arterioscler Thromb Vasc Biol 23:508–511CrossRefPubMed
6.
go back to reference Soria JM, Almasy L, Souto JC, Buil A, Martínez-Sánchez E, Mateo J, Borrell M, Stone WH, Lathrop M, Fontcuberta J, Blangero J (2003) A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility. Blood 101:163–167CrossRefPubMed Soria JM, Almasy L, Souto JC, Buil A, Martínez-Sánchez E, Mateo J, Borrell M, Stone WH, Lathrop M, Fontcuberta J, Blangero J (2003) A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility. Blood 101:163–167CrossRefPubMed
7.
go back to reference Soria JM, Almasy L, Souto JC, Bacq D, Buil A, Faure A, Martínez-Marchán E, Mateo J, Borrell M, Stone W, Lathrop M, Fontcuberta J, Blangero J (2002) A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. Am J Hum Genet 70:567–574CrossRefPubMed Soria JM, Almasy L, Souto JC, Bacq D, Buil A, Faure A, Martínez-Marchán E, Mateo J, Borrell M, Stone W, Lathrop M, Fontcuberta J, Blangero J (2002) A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. Am J Hum Genet 70:567–574CrossRefPubMed
8.
go back to reference Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K (2004) The gene encoding 5-lypoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36:233–239CrossRefPubMed Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K (2004) The gene encoding 5-lypoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36:233–239CrossRefPubMed
9.
go back to reference Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603CrossRefPubMed Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603CrossRefPubMed
10.
go back to reference Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606CrossRefPubMed Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606CrossRefPubMed
11.
go back to reference Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, Stone WH, Blangero J, Fontcuberta J (2000) Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101:1546–1551PubMed Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, Stone WH, Blangero J, Fontcuberta J (2000) Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101:1546–1551PubMed
12.
go back to reference Sullivan JL (1999) Iron and genetics of cardiovascular disease. Circulation 100:1260–1263PubMed Sullivan JL (1999) Iron and genetics of cardiovascular disease. Circulation 100:1260–1263PubMed
13.
go back to reference Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG, Sixma JJ, Banga JD (1999) Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 100:1268–1273PubMed Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG, Sixma JJ, Banga JD (1999) Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 100:1268–1273PubMed
14.
go back to reference Souto JC, Almasy L, Borrell M, Stone WH, Blaco-Vaca F, Soria JM, Blangero J, Fontcuberta J (2002) Thromboplastin–thrombomodulin-mediated time and serum folate levels are genetically correlated with risk of thromboembolic disease: results from the GAIT project. Thromb Haemost 87:68–73PubMed Souto JC, Almasy L, Borrell M, Stone WH, Blaco-Vaca F, Soria JM, Blangero J, Fontcuberta J (2002) Thromboplastin–thrombomodulin-mediated time and serum folate levels are genetically correlated with risk of thromboembolic disease: results from the GAIT project. Thromb Haemost 87:68–73PubMed
15.
go back to reference Souto JC, Remacha A, Buil A, Almasy L, Blangero J, Fontcuberta J (2003) Genetic determinants of iron metabolism plasma phenotypes and their relationship with risk of thrombosis. Haematologica 88:1436–1438PubMed Souto JC, Remacha A, Buil A, Almasy L, Blangero J, Fontcuberta J (2003) Genetic determinants of iron metabolism plasma phenotypes and their relationship with risk of thrombosis. Haematologica 88:1436–1438PubMed
16.
go back to reference Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198–1211CrossRefPubMed Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198–1211CrossRefPubMed
17.
go back to reference Souto JC, Almasy L, Blangero J, Stone W, Borrell M, Urrutia T, Mateo J, Fontcuberta J (2001) Genetic regulation of plasma levels of vitamin-K dependent proteins involved in hemostasis. Thromb Haemost 85:88–92PubMed Souto JC, Almasy L, Blangero J, Stone W, Borrell M, Urrutia T, Mateo J, Fontcuberta J (2001) Genetic regulation of plasma levels of vitamin-K dependent proteins involved in hemostasis. Thromb Haemost 85:88–92PubMed
18.
go back to reference Whitfield JB, Martin NG (1984) The effects of inheritance on constituents of plasma: a twin study on some biochemical variables. Ann Clin Biochem 21:176–183PubMed Whitfield JB, Martin NG (1984) The effects of inheritance on constituents of plasma: a twin study on some biochemical variables. Ann Clin Biochem 21:176–183PubMed
19.
go back to reference Moyo VM, Mandishona E, Hasstedt SJ, Gangaidzo IT, Gomo ZAR, Khumalo H, Saungweme T, Kiire CF, Paterson AC, Bloom P, Mac Phail AP, Rouault T, Gordeuk VR (1998) Evidence of genetic transmission in African iron overload. Blood 91:1076–1082PubMed Moyo VM, Mandishona E, Hasstedt SJ, Gangaidzo IT, Gomo ZAR, Khumalo H, Saungweme T, Kiire CF, Paterson AC, Bloom P, Mac Phail AP, Rouault T, Gordeuk VR (1998) Evidence of genetic transmission in African iron overload. Blood 91:1076–1082PubMed
20.
go back to reference Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C (2003) Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood 102:1904–1910CrossRefPubMed Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C (2003) Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood 102:1904–1910CrossRefPubMed
21.
go back to reference Visapaa I, Fellman V, Vesa J, Dasvarma A, Hutton JL, Kumar V, Payne GS, Makarow M, Van Coster R, Taylor RW, Turnbull DM, Suomalainen A, Peltonen L (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863–876CrossRefPubMed Visapaa I, Fellman V, Vesa J, Dasvarma A, Hutton JL, Kumar V, Payne GS, Makarow M, Van Coster R, Taylor RW, Turnbull DM, Suomalainen A, Peltonen L (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863–876CrossRefPubMed
22.
go back to reference Esparza-Gordillo J, Soria JM, Buil A, Souto JC, Almasy L, Blangero J, Fontcuberta J, de Cordoba SR (2003) Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families. Immunogenetics 54:862–866PubMed Esparza-Gordillo J, Soria JM, Buil A, Souto JC, Almasy L, Blangero J, Fontcuberta J, de Cordoba SR (2003) Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families. Immunogenetics 54:862–866PubMed
Metadata
Title
Genomewide linkage analysis of soluble transferrin receptor plasma levels
Authors
Angel F. Remacha
Joan C. Souto
José Manuel Soria
Alfonso Buil
M. Pilar Sardà
Mark Lathrop
John Blangero
Laura Almasy
Jordi Fontcuberta
Publication date
01-01-2006
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 1/2006
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-005-1092-7

Other articles of this Issue 1/2006

Annals of Hematology 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.